The 340B Drug Pricing Program reduces high drug costs for safety-net providers and programs so they can stretch limited resources and better serve their patients and communities.
Safety-net providers, vulnerable patients and communities rely on 340B
Republicans and Democrats are united in their support for 340B
“The 340B program has been critical to supporting safety-net providers in helping low-income and vulnerable individuals across the country access affordable, comprehensive health care services for more than 25 years.”December 2017 Bipartisan Letter to Senate Leadership Asking to Stop Cuts to 340B Hospitals
“The long-term success of the 340B program is imperative.”October 2017 Bipartisan Senate Letter to Stop Cuts to 340B Hospitals
“Given the important role that the 340B program plays in our communities, we strongly urge CMS to abandon this proposal and redirect its efforts toward actions to address the cost of drugs via other policies that would not harm our constituents.”September 2017 House bipartisan letter of support to stop cuts to 340B hospitals
“Thanks to 340B, our hospitals are able to expand services, increase the number of patients they serve, and offset losses from uncompensated care…”July 2014 House bipartisan letter of support
“Since its creation in 1992, the 340B program has allowed hundreds of hospitals and other safety net providers across the country do more with less.”July 2014 Senate bipartisan letter of support
“The 340B program has reduced federal and state government spending on prescription drugs by billions of dollars”August 2013 Senate bipartisan letter of support
“On behalf of the millions of our neighbors who rely upon safety net providers, we urge you to resist any legislative efforts to change the law’s mission—to help safety net providers…”August 2013 House bipartisan letter of support
There’s a lot of misinformation out there. Get the facts
340B was intended to deliver discounted drugs directly to patients.
340B was created to allow safety-net providers to buy outpatient medicines for less. They use the savings to stretch resources so they can provide a variety of services, drugs, and better care to patients who can’t always pay.
340B uses taxpayer money.
340B is not funded by taxpayers. Instead, drug companies sell drugs to providers at discounted prices, allowing them to stretch their existing funding even further. A government agency, the Office of Pharmacy Affairs, receives a small congressional appropriation to administer the program.
Too many providers qualify for 340B.
Both Republicans and Democrats have expanded 340B to cover those parts of the safety net people need most. For example, the most recent expansion added small rural hospitals with 25 or fewer beds that guarantee access to care in some of the most remote parts of our country.